Singapore HSA Medical Device Registration Guide (2026): Complete Process, Fees, Timelines & Requirements

Overview of Singapore's Medical Device Market

Singapore is the premier medical device hub in Southeast Asia, with a market valued at approximately $1.94 billion growing at a CAGR of 8.35%. The city-state's strategic location, world-class healthcare system, and regulatory efficiency make it the gateway for international manufacturers entering the broader ASEAN region.

Singapore's IVD market is valued at approximately $220 million with a CAGR of 5.47%, reflecting strong investment in diagnostics and laboratory medicine.

Medical devices are regulated by the Health Sciences Authority (HSA) under the Health Products Act and the Health Products (Medical Devices) Regulations 2010. Singapore is a founding member of ASEAN and its classification and registration schemes are aligned with the ASEAN Medical Device Directive (AMDD).

Singapore also participates in the Singapore–Malaysia Pilot Program (launched August 2025) for mutual regulatory recognition, creating a potential cascade pathway across multiple ASEAN markets.

Regulatory Framework

Key Legislation

Regulation	Date	Purpose
Health Products Act	2007	Primary legislation for health product regulation
Health Products (Medical Devices) Regulations 2010	2010	Detailed requirements for medical device registration, import, and supply
GN-15: Guidance on Medical Device Product Registration (Rev 13)	March 2026	Comprehensive guidance on registration process, evaluation routes, and dossier requirements
Health Products (Medical Devices) (Amendment) Regulations	Various	Updates to classification, fees, and post-market requirements

Regulatory Authority

Health Sciences Authority (HSA) — Health Products Regulation Group (HPRG). HSA is responsible for:

• Registration of Class B, C, and D medical devices
• Dealer's licence issuance (Manufacturer, Importer, Wholesaler)
• Post-market surveillance and vigilance
• Clinical trial oversight for medical devices
• Advertising and promotion approval

Device Classification

Singapore classifies medical devices into four risk classes, consistent with the ASEAN/GHTF framework:

Class	Risk Level	Registration Requirement	Examples
Class A	Low risk	Notification only (no product registration)	Non-sterile bandages, manual wheelchairs, surgical retractors
Class B	Low to moderate risk	Product registration required	Infusion pumps, suction devices, powered wheelchairs
Class C	Moderate to high risk	Product registration required	Blood glucose meters, HF surgical devices, ventilators
Class D	High risk	Product registration required	Implantable pacemakers, heart valves, surgical robots

Classification Rules

Classification follows the AMDD rules based on:

• Intended purpose (what the manufacturer claims the device does)
• Duration of use (transient, short-term, long-term)
• Invasiveness (non-invasive, body orifice, surgically invasive)
• Active nature (active vs. non-active devices)
• Software risk (for Software as a Medical Device — SaMD)

Manufacturers are responsible for self-classifying their devices. HSA may reclassify during review if the submitted classification is incorrect.

Evaluation Routes

HSA offers five evaluation routes for medical device registration, depending on the device's prior approval history and risk level:

Immediate Route

• Available for: Class B devices with approval from at least one reference regulatory agency; Class C standalone medical mobile applications
• Timeline: Immediate registration upon submission
• Key requirement: Valid market authorization from US FDA, EU (CE), Health Canada, Australia TGA, or Japan PMDA
• Class B fee: SGD $1,000
• Class C fee (mobile apps only): SGD $3,340

Expedited Route

• Available for: Class C devices with approval from at least one reference regulatory agency; Class D devices with approval from at least two reference regulatory agencies
• Timeline: 120 working days (Class C), 180 working days (Class D)
• Class C fee: SGD $3,340
• Class D fee: SGD $5,930

Abridged Route

• Available for: Class B, C, and D devices with approval from at least one reference regulatory agency but not qualifying for Immediate or Expedited routes
• Timeline: 100 working days (Class B), 160 working days (Class C), 220 working days (Class D)
• Class B fee: SGD $2,010
• Class C fee: SGD $3,900
• Class D fee: SGD $6,250
• Class D with registrable drug: SGD $10,600

Full Route

• Available for: Class B, C, and D devices with no prior approval from any HSA-recognized overseas reference regulatory agency
• Timeline: 160 working days (Class B), 220 working days (Class C), 310 working days (Class D)
• Class B fee: SGD $3,900
• Class C fee: SGD $6,250
• Class D fee: SGD $12,000
• Class D with registrable drug: SGD $75,600

Priority Review Scheme

• Available for: Devices that meet specific criteria for unmet medical needs or breakthrough technology
• Two sub-routes:
  • Route 1: SGD $4,420 (Class B), SGD $7,000 (Class C), SGD $13,600 (Class D) — 104/143/202 working days
  • Route 2: SGD $5,660 (Class B), SGD $9,000 (Class C), SGD $17,500 (Class D) — 104/143/202 working days

Reference Regulatory Agencies

HSA recognizes the following agencies for Abridged/Expedited/Immediate routes:

• US FDA
• Health Canada
• EU member states (CE marking under EU MDR/MDD)
• Australia TGA
• Japan PMDA/MHLW

Registration Fees and Timelines Summary

Route	Class	Application Fee	Evaluation Fee	Total Fee (SGD)	Timeline (Working Days)
Immediate	B	$560	$1,000	$1,560	Immediate
Immediate	C (mobile app)	$560	$3,340	$3,900	Immediate
Abridged	B	$560	$2,010	$2,570	100
Abridged	C	$560	$3,900	$4,460	160
Abridged	D	$560	$6,250	$6,810	220
Abridged (Drug)	D	$560	$10,600	$11,160	220
Expedited	C	$560	$3,340	$3,900	120
Expedited	D	$560	$5,930	$6,490	180
Full	B	$560	$3,900	$4,460	160
Full	C	$560	$6,250	$6,810	220
Full	D	$560	$12,000	$12,560	310
Full (Drug)	D	$560	$75,600	$76,160	310
Priority (R1)	B	$560	$4,420	$4,980	104
Priority (R1)	C	$560	$7,000	$7,560	143
Priority (R1)	D	$560	$13,600	$14,160	202
Priority (R2)	B	$560	$5,660	$6,220	104
Priority (R2)	C	$560	$9,000	$9,560	143
Priority (R2)	D	$560	$17,500	$18,060	202

Annual Retention Fees

Class	Annual Retention Fee
Class B	SGD $39
Class C	SGD $67
Class D	SGD $134
Class D with registrable drug	SGD $134

Change Notification Fees

Change Type	Class B	Class C	Class D
Administrative changes	$560	$560	$560
Technical changes	N/A	$1,890	$3,120
Review changes	$560	N/A	N/A
Change of registrant	$880	$880	$880

Fees were updated effective July 1, 2024 with approximately 5% increases across most categories.

Who Can Register a Medical Device in Singapore

Local Registrant Requirement

Foreign manufacturers cannot apply directly to HSA. A Singapore-based entity must be appointed as the Product Registrant. This can be:

1. The manufacturer's own Singapore subsidiary — Maximum control but requires setting up a local entity and obtaining a dealer's licence.

2. A licensed Singapore importer/distributor — Fastest option; the distributor holds the registration. Risk: the distributor owns the registration and switching distributors requires a Change of Registrant application ($880, 40 working days).

3. An independent regulatory services firm — Acts as Registrant without commercial distribution conflicts. Can issue Letters of Authorization to multiple distributors.

Dealer's Licence

All entities involved in the supply chain must hold a valid HSA Dealer's Licence:

• Manufacturer's Licence — For manufacturing sites in Singapore
• Importer's Licence — Required for importing devices into Singapore
• Wholesaler's Licence — Required for wholesale distribution

The Registrant must hold at least an Importer's Licence or Wholesaler's Licence.

Required Documentation

ASEAN CSDT Dossier

All product registrations must be submitted in the ASEAN Common Submission Dossier Template (CSDT) format. The CSDT includes:

CSDT Section	Content
Section 1 — Administrative	Application form, device description, classification rationale, conformity summary, certificates (FSC/ISO 13485)
Section 2 — Essential Principles	Essential Principles checklist demonstrating safety and performance compliance
Section 3 — Design & Manufacturing	Device design, manufacturing processes, quality system documentation
Section 4 — Labeling	Labels, Instructions for Use (IFU), patient information
Section 5 — Risk Analysis	Risk management file per ISO 14971
Section 6 — Clinical Evidence	Clinical evaluation report, clinical data, literature review
Singapore-specific Annexes	Singapore labeling requirements, dealer's licence information, advertising compliance

Key Documents

• ISO 13485 certificate for the manufacturing facility (mandatory)
• Certificate of Free Sale (CFS) from country of origin or reference country approval letter
• Declaration of conformity to Essential Principles
• Clinical evaluation report — Required for Class B–D; must follow HSA guidance
• Risk management report per ISO 14971
• Labeling in English (Singapore accepts English for all labeling)

Language Requirements

All submissions and labeling are accepted in English — a significant advantage over many other ASEAN markets.

Step-by-Step Registration Process

Step 1 — Classify Your Device

Determine the risk class (A–D) based on AMDD classification rules. HSA's GN-13 guidance provides detailed classification instructions.

Step 2 — Appoint a Singapore Registrant

If you do not have a Singapore entity, appoint a local Registrant (importer, distributor, or independent regulatory services firm).

Step 3 — Obtain a Dealer's Licence

The Registrant applies for the appropriate dealer's licence through HSA. This is a prerequisite for product registration.

Step 4 — Prepare the CSDT Dossier

Compile the complete ASEAN CSDT dossier with Singapore-specific sections. Ensure ISO 13485 certificate is current and covers the correct manufacturing site.

Step 5 — Submit via SHARE Portal

Submit the registration application through SHARE (Singapore Health Product Access and Regulatory E-System) — HSA's online portal. Pay the application fee (SGD $560) at submission.

Step 6 — HSA Screening & Evaluation

HSA verifies the application for completeness and routes it to the correct evaluation pathway. Once accepted for evaluation, the evaluation fee is charged. HSA may issue queries during review — timely responses are critical to avoid extending the timeline.

Step 7 — Approval & SMDR Listing

Upon approval, the device is listed on the Singapore Medical Device Register (SMDR). The device can now be imported and supplied in Singapore.

Step 8 — Maintain Compliance

• Pay annual retention fees to maintain SMDR listing
• Submit change notifications for any modifications to the registered device
• Report adverse events and field safety corrective actions
• Maintain valid dealer's licences

Class A Devices — Notification Process

Class A devices are exempt from product registration but must still comply with:

• Essential Principles for Safety and Performance
• Quality Management System requirements
• International sterilization standards (if supplied sterile)

The importer must hold a valid dealer's licence. Notification is processed immediately upon submission.

SaMD and AI/ML Devices

HSA updated its SaMD guidance in December 2025 with expanded requirements for AI medical devices:

• Most clinical SaMD is classified as Class B or C
• AI diagnostic tools are typically Class C or D
• Change management rules have been revised — algorithm updates may require change notifications
• Pre-submission meetings with HSA are recommended for complex AI/ML devices
• Cybersecurity documentation is increasingly required for connected devices

Singapore–Malaysia Regulatory Reliance Pilot

Launched in August 2025, this pilot program allows:

• Devices approved by Singapore HSA to potentially receive expedited review by Malaysia MDA
• A potential ASEAN cascade pathway: EU MDR → Singapore HSA (3–9 months) → Malaysia MDA (3 months) → potentially Thailand and Philippines

This pilot represents a significant step toward intra-ASEAN regulatory recognition and could substantially reduce multi-market registration timelines.

Special Access Routes

HSA provides pathways for unregistered devices in specific circumstances:

Route	Fee	Timeline
Import for re-export	SGD $280	14 working days
Non-clinical purpose	SGD $280	14 working days
Requested by qualified practitioner	SGD $168	14 working days
Requested by licensed healthcare facility	SGD $390	14 working days

Common Challenges and How to Avoid Them

1. Choosing the Wrong Evaluation Route

If HSA determines the application does not qualify for the selected route, it will be re-routed — and higher evaluation fees may apply. Carefully review eligibility criteria before selecting a route.

2. Slow Query Responses

HSA issues clarification requests during review. Delayed responses extend the timeline significantly. Designate a responsive regulatory contact.

3. Incomplete CSDT Dossiers

Incomplete submissions are the most common cause of delays. Ensure all CSDT sections are complete before submission, particularly clinical evidence and risk analysis.

4. Dealer's Licence Issues

The Registrant's dealer's licence must be valid and current at the time of application and throughout the product's market life. Lapses can result in registration suspension.

5. Incorrect Classification

HSA may reclassify devices during review, which can change the applicable evaluation route and fees. Classify conservatively and consult HSA guidance documents.

Total Cost Estimate

Cost Item	Estimated Range
Government fees (Class B, Immediate route)	SGD $1,560 ($1,180)
Government fees (Class C, Abridged route)	SGD $4,460 ($3,370)
Government fees (Class D, Full route)	SGD $12,560 ($9,500)
Government fees (Class D, Abridged route)	SGD $6,810 ($5,150)
Application fee (all classes)	SGD $560 (~$425)
Annual retention fee	SGD $39–134/year
Local Registrant fees (annual)	$2,000–$10,000
Regulatory consultant (dossier preparation)	$5,000–$20,000
Total estimated cost per device	$8,000–$40,000

USD amounts approximate based on SGD 1 ≈ USD 0.76.

Key Takeaways

• English-language submissions accepted — no translation costs, unlike most ASEAN markets
• Multiple evaluation routes — Immediate registration possible for Class B devices with reference country approval
• CSDT format required — aligned with ASEAN, enabling multi-country submissions
• Annual retention fees are very low (SGD $39–134/year)
• Singapore–Malaysia pilot (2025) creates potential ASEAN cascade pathway
• Foreign manufacturers must appoint a local Registrant — cannot apply directly
• SHARE portal for all electronic submissions
• SaMD/AI guidance updated December 2025 — expanded requirements for AI devices
• Plan 3–18 months for registration depending on device class and evaluation route

2026 Regulatory Updates

GN-15 Revision 13 (March 2026)

HSA released the latest revision of its comprehensive product registration guidance. Key updates include clarified evaluation route eligibility criteria, updated fee references, and revised processing timelines. All new applications should follow GN-15 Rev 13 requirements.

SaMD and AI Guidance Expansion (December 2025)

HSA expanded its guidance on software as a medical device with new requirements for AI/ML-based devices. The update introduces stricter change management rules for algorithm updates and recommends pre-submission meetings for complex AI devices.

Digital Health Innovation Office

HSA has established an Innovation Office for Medical Devices to support companies developing novel digital health products, including AI diagnostics and connected medical devices. The office provides pre-submission consultation and regulatory guidance for innovative technologies.

MDA–Singapore Regulatory Reliance Pathway Continued (March 2026)

Malaysia's Medical Device Authority (MDA) confirmed on March 1, 2026 that the Malaysia MDA – Singapore HSA Regulatory Reliance Pathway will continue following the successful completion of the initial six-month pilot period (September 2025 – February 2026). Under this pathway, devices registered with Malaysia MDA through full conformity assessment can apply for Singapore registration under the Abridged evaluation route with reduced documentation requirements: a copy of the MDA Registration Certificate, Certificate of Conformity issued by a CAB, and standard GN-15 documents. Conversely, devices listed on the Singapore Medical Device Register can leverage Singapore approval for Malaysia registration through the Verification Route. Both HSA and MDA websites have been updated to reflect this continuation.

SHARE Portal Enhancements

HSA continues to improve the SHARE portal with streamlined submission workflows, improved document management, and enhanced query response tracking. All device registrations must be submitted through SHARE.

ACRA and CRIS Registration for New Entities

Companies new to Singapore must first register with the Accounting and Corporate Regulatory Authority (ACRA) before engaging with HSA. After ACRA registration, companies create a Client Registration and Identification Service (CRIS) account with HSA, which provides access to the SHARE portal for all regulatory transactions, including dealer's licence applications and product registrations.

Frequently Asked Questions

How long does HSA medical device registration take?

Timelines depend on the evaluation route. Immediate route: same day. Abridged route: 100–220 working days by class. Full route: 160–310 working days. Budget 3–18 months total including preparation time.

Is Singapore HSA registration recognized in other ASEAN countries?

Singapore's approval is increasingly recognized. The Singapore–Malaysia pilot program (2025) enables reliance pathways, and Singapore approval can support registrations in the Philippines and other ASEAN markets through reference country mechanisms.

Can I use my EU MDR CE marking for expedited registration?

Yes. CE marking under EU MDR is recognized by HSA for the Immediate, Expedited, and Abridged routes, significantly reducing registration time and cost.

Do I need ISO 13485 certification?

Yes. A valid ISO 13485 certificate covering the manufacturing facility is mandatory for all Class B–D device registrations.

What is the SHARE portal?

SHARE (Singapore Health Product Access and Regulatory E-System) is HSA's online portal for all medical device registration submissions, dealer's licence applications, and change notifications.

Can I change my Registrant?

Yes. A Change of Registrant application costs SGD $880 and takes approximately 40 working days. The new registrant must hold a valid dealer's licence.

Does Singapore require UDI for medical devices?

Singapore is implementing UDI requirements in alignment with ASEAN harmonization efforts. Check current requirements on the HSA website at the time of application.

What post-market obligations exist in Singapore?

Registrants must report adverse events, conduct field safety corrective actions when needed, submit change notifications for device modifications, and pay annual retention fees to maintain SMDR listing.

Are clinical trials required?

Clinical trials in Singapore are not automatically required. HSA accepts clinical data from reference countries and published literature. However, HSA may request additional clinical data for novel devices or devices without adequate clinical evidence.